Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study
Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals
Transgender people are at high risk for HIV, but too little is known about prevention and treatment for this population
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs
Study reveals potential challenges for scaling up of HCV therapy in UK
How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations
Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs
